Consumption of UPFs increases the risk of cancer and cardiometabolic multimorbidity

The association between UPF consumption and cancer, cardiovascular disease, and type 2 diabetes.

FDA Approves Another SGLT2 Inhibitor for Treating CKD

The SGLT2 inhibitor empagliflozin (Jardiance) nabbed a new indication for the treatment of adults with chronic kidney disease (CKD) regardless of diabetes status, Boehringer Ingelheim

September 23, 2023

Opinion | Keep Quality Measures Out of the Exam Room

Millstein is an attending physician. The patient’s check-up begins, as most now do, by sitting down and typing my username and password into a computer.

January 5, 2025

BioAegis scores $20m BARDA contract to develop ARDS therapy – Pharmaceutical Technology

ARDS causes a fluid build-up in the lungs resulting from a severe complication of pneumonia, sepsis, Covid-19, or trauma. Image Credit: Design_Cells / Shutterstock. The

October 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.